Alberta Investment Management Corp Aurinia Pharmaceuticals Inc. Transaction History

Alberta Investment Management Corp

  • $10.2 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$10.93 - $23.55 $569,453 - $1.23 Million
-52,100 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$10.0 - $14.52 $24,000 - $34,848
2,400 Added 4.83%
52,100 $676,000
Q1 2021

May 07, 2021
SELL
$12.3 - $18.73 $329,640 - $501,964
-26,800 Reduced 35.03%
49,700 $646,000
Q4 2020

Feb 16, 2021
BUY
$12.94 - $16.05 $5,176 - $6,420
400 Added 0.53%
76,500 $1.05 Million
Q3 2020

Oct 26, 2020
BUY
$13.19 - $16.66 $1 Million - $1.27 Million
76,100 New
76,100 $1.12 Million

Others Institutions Holding AUPH

# of Institutions
207
Shares Held
58.3M
Call Options Held
914K
Put Options Held
1.35M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email